Articles related to Oncology, Surgical

“In light of recent findings, it is crucial to evaluate the implications of modified mRNA in therapeutic uses, particularly its role in immune response and potential cancer progression.”

In the recent KEYNOTE-564 trial, adjuvant pembrolizumab therapy was shown to increase the 48-month overall survival rate to 91.2% compared to 86.0% with placebo among post-surgical patients with renal-cell carcinoma at increased risk of recurrence.

This comprehensive review underscores the increasing incidence of esophageal adenocarcinoma and highlights the integration of advanced endoscopic techniques and novel screening tools, which are critical in the early detection and management of this challenging disease.

The recent FDA approval of Lumicell’s breast cancer imaging system introduces a novel intraoperative tool that significantly enhances the precision of tumor resections, potentially reducing the need for subsequent corrective surgeries.

Explore the indicators of lung cancer, including persistent cough and unexplained weight loss, which may help in its early detection and improve patient outcomes.

In light of recent disruptions, it’s crucial for healthcare systems to reconsider how consolidation impacts patient care and to explore diverse value-based care models that prioritize patient outcomes.